Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: A stability assessment

Journal of Oncology Pharmacy Practice

Volumn 19, Issue 1, 2013, Pages 65-74

  Hecq, Jean Daniel ^a   Lewis, Andrew L ^b   Vanbeckbergen, Danielle ^a   Athanosopoulos, Alexandre ^c   Galanti, Laurence ^a   Jamart, Jacques ^a   Czuczman, Peter ^b   Chung, Ting ^b  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b BIOCOMPATIBLES UK LTD   (United Kingdom)

^c Drug Stability Research Group   (Belgium)

Author keywords

chemoembolisation; doxorubicin; Drug eluting bead; high performance liquid chromatography; stability

Indexed keywords

DC BEAD; DOXORUBICIN; IONIC CONTRAST MEDIUM; POLYPROPYLENE; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG;

ARTICLE; CHEMOEMBOLIZATION; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; DRUG PACKAGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROGEL; PRIORITY JOURNAL; SYRINGE;

ANTIBIOTICS, ANTINEOPLASTIC; CHEMOEMBOLIZATION, THERAPEUTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONTRAST MEDIA; DOXORUBICIN; DRUG CARRIERS; DRUG COMPOUNDING; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; GLASS; IOHEXOL; KINETICS; MICROSPHERES; POLYPROPYLENES; POLYVINYL ALCOHOL; REFRIGERATION; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; SYRINGES;

EID: 84874465635     PISSN: 10781552     EISSN: 1477092X     Source Type: Journal    
DOI: 10.1177/1078155212452765     Document Type: Article

References (29)

1. Llovet JM, Real MI, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002 ; 359: 1734-1739
2. Lo CM, Ngan H, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002 ; 35: 1164-1171
3. Lewis AL, Gonzalez MV, et al. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol. 2006 ; 17: 335-342
4. Gonzalez MV, Tang Y, et al. Doxorubicin eluting beads - 2: methods for evaluating drug elution and in-vitro: invivo correlation. J Mater Sci Mater Med. 2007 ; 19: 767-775
5. Lewis AL, Gonzalez MV, et al. Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution. J Mater Sci Mater Med. 2007 ; 18: 1691-1699
6. Lewis AL. DC Bead®: a major development in the toolbox for the interventional oncologist. Expert Rev Med Devices. 2009 ; 6: 389-400
7. Hong K, Khwaja A, et al. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res. 2006 ; 12: 2563-2567
8. Varela M, Real MI, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007 ; 46: 474-481
9. Poon RTP, Tso WK, et al. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol. 2007 ; 5: 1100-1108
10. Dhanasekaran R, Kooby DA, et al. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC). J Surg Oncol. 2010 ; 101: 476-480
11. Malagari K, Pomoni M, et al. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2010 ; 33: 541-551
12. Malagari K, Alexopoulou E, et al. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. Abdom Imaging. 2008 ; 33: 512-519
13. Kettenbach J, Stadler A, et al. Drug-loaded beads for the treatment of liver cancer: review of current results. Cardiovasc Intervent Radiol. 2008 ; 31: 468-476
14. Malagari K, Chatzimichael K, et al. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Intervent Radiol. 2008 ; 31: 269-280
15. Lammer J, Malagari K, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010 ; 33: 41-52
16. Fiorentini G, Aliberti C, et al. Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study. In Vivo. 2007 ; 21: 1085-1092
17. Martin RC, Joshi J, et al. Transarterial chemoembolization of metastatic colorectal carcinoma with drug-eluting beads, irinotecan (DEBIRI): multi-institutional registry. J Oncol. 2009 ;:
18. Aliberti C, Benea G, et al. Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results. Cardiovasc Intervent Radiol. 2008 ; 31: 883-888
19. de Baere T, Deschamps F, et al. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results. J Vasc Interv Radiol. 2008 ; 19: 855-861
20. Kaiser J, Thiesen J, et al. Stability of irinotecan-loaded drug eluting beads (DC Bead) used for transarterial chemoembolization. J Oncol Pharm Pract. 2010 ; 16: 53-61
21. Walker S, Lau D, et al. Doxorubicin stability in syringes and glass vials and evaluation of chemical contamination. Can J Hosp Pharm. 1991 ; 44 :
22. Poochikian GK, Cradock JC, et al. Stability of anthracycline antitumor agents in four infusion fluids. Am J Hosp Pharm. 1981 ; 38: 483-486
23. Beijnen JH, Rosing H, et al. Stability of anthracycline antitumour agents in infusion fluids. J Parenter Sci Technol. 1985 ; 39: 220-222
24. Beijnen JH, Neef C, et al. Stability of intravenous admixtures of doxorubicin and vincristine. Am J Hosp Pharm. 1986 ; 43: 3022-3027
25. Benvenuto JA, Anderson RW, et al. Stability and compatibility of antitumor agents in glass and plastic containers. Am J Hosp Pharm. 1981 ; 38: 1914-1918
26. Wood MJ, Irwin WJ, et al. Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags. J Clin Pharm Ther. 1990 ; 15: 279-289
27. Dine T, Cazin JC, et al. Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags. Pharm Weekbl Sci. 1992 ; 14: 365-369
28. Allen LV, Stiles ML, et al. Stability of 14 drugs in the latex reservoir of an elastomeric infusion device. Am J Health Syst Pharm. 1996 ; 53: 2740-2743
29. Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharmaceut Technol. 1996 ; 20: 64-74